The blue-chip NSE Nifty 50 index shed 1.38 per cent to 17,677.75 and the benchmark S&P BSE Sensex dropped nearly 1.5 per cent to 59,341.06
Indian shares dropped more than 1 per cent on Thursday, weighed down by losses in financial and technology stocks, as an alarming spike in daily Covid-19 cases and a hawkish stance by the U.S. Federal Reserve spooked investors.
The blue-chip NSE Nifty 50 index shed 1.38 per cent to 17,677.75 by 0520 GMT and the benchmark S&P BSE Sensex dropped nearly 1.5 per cent to 59,341.06 after a four-session winning streak. Despite the session’s losses, both indexes were up about 2 per cent for the week.
Indian shares also tracked weakness in global markets after minutes of the U.S. Federal Reserve’s December policy meeting pointed to quicker interest rate hikes to tame persistently high inflation.
India’s daily Covid-19 cases climbed 57 per cent in a day to 90,928, raising fears of more restrictions and concerns about its impact on the economic recovery.
In Mumbai, all major Nifty sub-indexes were trading in negative territory, with the banking sector down 1.3 per cent after five straight sessions of gains.
Indian markets are likely to consolidate till the budget is announced. The first two quarters of the financial year saw brilliant earnings growth despite margin contractions and the same is expected this quarter as well, said Amit Gupta, a fund manager at ICICI Securities.
The Nifty IT index, which was among the top performing sectors last year, extended losses to a second day and was down 1.48 per cent.
Analysts said while stellar-performing IT stocks could see profit-booking in the near-term, they will continue to do well on prospects of decent revenue growth.
Shares of oils-to-telecom heavyweight Reliance Industries fell 2 per cent and were among the top drags to the benchmark indexes.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.